Xenon Presents 48-Month Azetukalner OLE Data for Epilepsy at AES
05 Dec 2025 //
GLOBENEWSWIRE
Xenon To Unveil Azetukalner OLE Study Results In Epilepsy At AES
25 Nov 2025 //
GLOBENEWSWIRE
Xenon Names Tucker Kelly as CFO
16 Oct 2025 //
GLOBENEWSWIRE
05 Dec 2025 //
GLOBENEWSWIRE
25 Nov 2025 //
GLOBENEWSWIRE
16 Oct 2025 //
GLOBENEWSWIRE
Market Place
Sourcing Support